This Solicitation opportunity from Department Of Defense was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
AMITRIPTYLINE HYDRO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract solicitation SPE2DP-26-T-3413 is for the procurement of 10 milligram amitriptyline hydrochloride tablets, USP, in film-coated form, packaged in bottles of 100 tablets each, with the unit of issue defined as a bottle (BT). The item is regulated by the FDA and requires compliance with strict quality and packaging standards, including a mandatory 36-month non-extendable shelf life designated as TYPE I (CODE Q) under RS001. Packaging and labeling must adhere to MIL-STD-129 for marking and barcoding, Medical Marking Standard No. 1 for pharmaceutical items, and DLA’s RP001 for palletization. All packaging must meet DLA’s Master List of Technical and Quality Requirements, which supersedes ASTM D3951 even for non-hazardous materials, and if classified as hazardous under FED-STD-313, packaging must conform to IP025. Storage conditions require protection from light and temperature control between 20°C and 25°C (68°F to 77°F). Delivery is FOB Destination to Fort Bragg, North Carolina, with a strict 20-day delivery window after award and no variance allowed in quantity. The item must be shipped by the fastest traceable means with parcel post prohibited. The contract is issued by the Department of Defense’s Medical Supply Chain Pharm FSA, with James Mariani as the primary point of contact. Invoicing must be processed electronically through Wide Area WorkFlow (WAWF), and the awardee must comply with all FAR and DFARS clauses, including those related to combating human trafficking, employment eligibility verification, sustainable products, safeguarding defense information, and cybersecurity requirements under NIST SP 800-171. The contracting vehicle allows for automated award under simplified acquisition procedures, though the specific contract type has not been filled in. Offerors must be registered in SAM, provide their UEI and CAGE codes, and validate social and economic certifications where applicable. All submissions are exclusively electronic via the DIBBS portal, with a firm response deadline of May 20, 2026.
General Info
Agency
Contract Value
$15.88NAICS
Place of Performance
2530 TAYLOR STREET BLDG NUMBER 2530, FORT BRAGG, NC, 28310, USASet-Aside
Awardee
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP<(>,<)> RX ONLY<(>,<)>
EACH FILM-COATED TABLET, FOR ORAL ADMINISTRATION CONTAINS 10 MILLIGRAMS
OF AMITRIPTYLINE HYDROCHLORIDE
.
UNIT OF ISSUE IS A BOTTLE CONTAINING 100 TABLETS.
STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE]
.
PROTECT FROM LIGHT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 100 TT
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/ RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SANDOZ INC. 0THL4 P/N NDC00781-1486-00 CARDINAL HEALTH, INC. 00E55 P/N NDC00781-1486-01 AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00781-1486-01 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0739-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3413
SECTION B
PR: 7016783836 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016783836 0001 BT 1.000
NSN/MATERIAL:6505000797453
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W8002S
0189 CS BN CO A COMPOSITE
AWCF SSA
2530 TAYLOR STREET BLDG NUMBER 2530
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W8002S
0189 CS BN CO A COMPOSITE
AWCF SSA
2530 TAYLOR STREET BLDG NUMBER 2530
FORT BRAGG NC 28310
US
MARKFOR
W8002S
0189 CS BN CO A COMPOSITE
AWCF SSA
2530 TAYLOR STREET BLDG NUMBER 2530
FORT BRAGG NC 28310
US
SPE2DP-26-T-3413
SECTION B
PR: 7016783836 PRLI: 0001 CONT’D
M/F: (TCN) W8002S61330264
RDD: 148
PROJ: TP 2
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3413 NSN/Part Number: 6505-00-079-7453 Quantity: 1 BT Purchase Request: 7016783836QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS